Morgan Lee Lekstrom

Interim Executive Chairman purchases 50,000 shares at blended $1.00; stock trading -86.3% from 52-week high amid $-46.7M net loss

Morgan Lee Lekstrom made 2 separate purchases totaling 50,000 shares for $49,750.00 on 2026-06-12, increasing his holdings by 16.2% to 359,500 shares. The purchases occurred at prices ($1.01 and $0.98) near current levels ($1.02), but within a context of severe price deterioration: the stock is -86.3% from its 52-week high of $7.44. The company reports revenue of $13,000.00 for the latest quarter and a net loss of $-46.7M over its most recent full fiscal year, indicating substantial unprofitability. At the same ticker, Lekstrom's prior measurable buy from 2026-02-18 delivered a 90-day return of -52.4%, and across his cross-ticker open-market history, his 11 prior buys averaged a 90-day return of -62.9% with a 0.00% win rate. The current purchase adds to a pattern of frequent recent accumulation at STEX (4 prior buys within the past three weeks) against deteriorating fundamentals and a dismal prior trade-outcome record.

Interim Chair Lekstrom purchases 34,000 STEX shares at $1.47; 90-day win rate 0.00% on prior STEX buys, stock down 79.0% from 52-week high.

Morgan Lee Lekstrom, Interim Executive Chairman, purchased 34,000 shares ($49,980.00) on 2026-05-28, increasing holdings to 309,000 shares (309.0K shares). This represents a +12.4% increase in his position. However, this buy follows a concerning pattern: across his 5 prior trades at STEX, zero achieved positive 90-day returns post-purchase, with prior buys declining 23.4% to 40.0% over 30 days and 52.4% to 77.0% over 90 days. The stock is currently 79.0% below its 52-week high of $7.44, and the company reported a net loss of $-46.7M against quarterly revenue of $13.0K, indicating severe profitability challenges. While the stock has risen 74.5% in the past 30 days, this rebound has not altered the insider's historical pattern of negative medium-term outcomes at this ticker.

Interim Executive Chairman Morgan Lee Lekstrom bought 147,000 shares of STEX for $153,099.04 across 3 transactions at $1.02–$1.06.

Morgan Lee Lekstrom purchased 147,000 shares in three separate transactions on 2026-05-21 at prices ranging from $1.02 to $1.06, increasing his holdings from 122,500 shares to 269,500 shares. The current stock price of $1.13 sits -84.8% from the 52-week high of $7.44 and has fallen -47.2% over the prior 90 days, despite a +13.0% gain over the past 30 days. Across his prior five purchases at STEX, all five resulted in negative 90-day returns, with declines ranging from -52.4% to -77.0%, establishing a pattern where 0 of 5 prior buys were well-timed. The company reported a net loss of $-46,693,000.00 in its most recent period against revenue of only $13,000.00, underscoring severe operational distress that contextualizes the depressed share price.

Executive Chairman Lekstrom Morgan Lee bought 20,000 shares of STEX at $2.50 on 2026-02-18; stock now down -66.0% from 52-week high at $2.38.

Lekstrom Morgan Lee, Executive Chairman of Streamex Corp., purchased 20,000 shares at $2.50 on 2026-02-18, increasing his holdings by 19.5% to 122,500 shares. This is the sixth buy from the same insider within a narrow window (five prior buys at STEX between 2026-01-23 and 2026-02-03), suggesting sustained accumulation. However, the stock is currently trading at $2.38, down -66.0% from its 52-week high of $7.00 and down -32.8% over the past 30 days alone. The company reported negative net income of -$15.6M against quarterly revenue of $13.0K, indicating severe operational distress despite +122.2% annual revenue growth. The rapid, repeated share purchases during sharp price deterioration—combined with the company's unprofitable state—warrant careful attention to whether the insider has conviction in a turnaround or faces liquidity constraints that necessitate purchases at any price.

Director Lee bought 23,500 shares of STEX at $3.06; now holds 102,500. Cluster pattern: 2 other insiders also bought within 14 days.

Lekstrom Morgan Lee (Director) purchased 23,500 shares at $3.06 on 2026-02-03, increasing his holdings by +29.7% to 102,500 shares. This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated or peer-influenced activity. However, context tempers significance: the company reported net income of $-15.6M over its most recent full fiscal year and generated only $13.0K in latest-quarter revenue, indicating severe profitability challenges despite +122.2% annual revenue growth. The stock trades -52.6% from its 52-week high of $7.00, though it has recovered +6.8% over the prior 30 days. His same-ticker history shows four prior STEX purchases in late January 2026 (all outcomes not yet measurable), followed by a November 2025 buy that returned +5.9% at 30 days. The cluster activity warrants monitoring to distinguish whether insiders see fundamental recovery potential or are mechanically buying into a depressed valuation amid unprofitability.

Director Lekstrom Morgan Lee bought 2,500 shares of STEX at $3.70 on 2026-01-29; cluster pattern with 2 other insiders buying within 14 days amid unprofitability and -31.4% 90-day decline.

Lekstrom Morgan Lee purchased 2,500 shares at $3.70 as part of a cluster-buy pattern where two other insiders also acquired shares within the past 14 days. The transaction occurs in the context of significant headwinds: Streamex Corp. remains unprofitable with net income of $-15,584,000.00 over its most recent full fiscal year, and the stock has declined 31.4% over the past 90 days despite recovering 10.2% over the past 30 days from its lows. At the current price of $3.34, the stock trades 52.3% below its 52-week high of $7.00. The director's same-ticker purchase history at STEX shows prior buys on 2026-01-27, 2026-01-26, and 2026-01-23 (outcomes not yet measurable due to recency), plus a November 2025 buy with a 30-day return of +5.9%. The accumulation pattern and timing warrant tracking, particularly given the company's ongoing unprofitability despite 122.2% annual revenue growth.

Director Lekstrom Morgan Lee buys 23,000 shares of STEX at $3.30 in cluster pattern; stock -47.9% from 52-week high despite +122.2% revenue growth.

Lekstrom Morgan Lee acquired 23,000 shares for $75,900.00, increasing his holdings by 47.9% to 71,000 shares in a period where Streamex Corp. trades at $3.65, down 47.9% from its $7.00 52-week high. Two other insiders also purchased within the past 14 days, forming a coordinated buying cluster at significantly depressed valuations. The company showed strong revenue growth of 122.2% year-over-year but remains unprofitable with a $-15.6M net loss in the latest fiscal year, creating a tension between operational momentum and current financial losses. This multi-insider accumulation pattern at a 52-week nadir warrants examination of whether the underlying metrics justify the aggregate conviction, particularly given Streamex's continued unprofitability despite aggressive topline expansion.

Director Lekstrom Morgan Lee bought 5,500 shares of STEX at $3.12 on 2026-01-27; joins 2 other insiders buying in past 14 days amid +122.2% revenue growth but -$15.6M loss.

Lekstrom Morgan Lee purchased 5,500 shares at $3.12, increasing his holdings from 71,000 to 76,500 shares. This transaction occurs within a 14-day cluster of insider buying activity at Streamex Corp., suggesting coordinated management appetite for the stock. However, the company context is mixed: annual revenue growth reached +122.2%, yet the company posted a -$15.6M net loss over its most recent full fiscal year and continues unprofitable, with latest quarterly revenue of only $13.0K. The stock is currently trading at $3.65, down -47.9% from its 52-week high of $7.00, though it has rebounded +16.2% over the past 30 days. Lee's cross-ticker buying track record shows an average 30-day return of +5.9% on 3 prior purchases, but his same-ticker history at STEX shows two additional buys on 2026-01-26 and 2026-01-23 with outcomes not yet measurable. Investors should weigh the positive revenue momentum and insider buying cluster against the company's ongoing losses and weak quarterly financials.

Director Lekstrom Morgan Lee bought 41,000 shares of STEX at $3.13 on 2026-01-23, raising stake 585.7%; cluster pattern with 2 other recent insider buys.

Director Lekstrom Morgan Lee purchased 41,000 shares at $3.13 on 2026-01-23, expanding his position from 7,000 to 48,000 shares (+585.7%). The buy occurs in a cluster pattern—2 other insiders also acquired shares within the past 14 days—which is a notable coordinated signal. However, the company's fundamentals present a mixed picture: while annual revenue growth reached +122.2%, the company reported a net loss of $-15.6M in its most recent full fiscal year, with the latest quarter showing minimal revenue of $13.0K. The stock has declined 51.4% from its 52-week high of $7.00, currently trading at $3.40. Across his open-market history, the insider's prior buys averaged a 30-day return of +5.9%, though his timing has not been well-measured at the 90-day horizon. The cluster buy activity deserves monitoring against the company's negative profitability.

Director Lekstrom Morgan Lee purchases 7,000 STEX shares at $3.58; first holdings at unprofitable company down 47.0% from 52-week high.

Director Lekstrom Morgan Lee made a first-time purchase of 7,000 shares at $3.58 on 2025-11-21, resulting in zero prior holdings becoming 7,000 shares post-transaction. The timing occurs against substantial headwinds: the stock is -47.0% from its 52-week high, has declined -23.4% over the past 30 days, and Streamex is unprofitable with full-year net income of $-15.6M against Revenue of $13.0K (latest quarter). While annual revenue growth reached +122.2%, the company's negative profitability and depressed valuation relative to 52-week peaks creates an ambiguous signal about the director's view of near-term fundamentals or a longer-horizon conviction. The absence of prior trading history at this ticker limits inference about whether this purchase pattern is characteristic of this insider's typical decision-making.